Immunotherapeutic uses of CpG oligodeoxynucleotides
DM Klinman - Nature Reviews Immunology, 2004 - nature.com
Synthetic oligodeoxynucleotides (ODNs) that contain immunostimulatory CpG motifs trigger
an immunomodulatory cascade that involves B and T cells, natural killer cells and …
an immunomodulatory cascade that involves B and T cells, natural killer cells and …
[HTML][HTML] Novel adjuvants & delivery vehicles for vaccines development: a road ahead
The pure recombinant and synthetic antigens used in modern day vaccines are generally
less immunogenic than older style live/attenuated and killed whole organism vaccines. One …
less immunogenic than older style live/attenuated and killed whole organism vaccines. One …
Can innate immunity be enhanced to treat microbial infections?
BB Finlay, REW Hancock - Nature Reviews Microbiology, 2004 - nature.com
Innate immunity is a highly effective set of conserved mechanisms used by multicellular
organisms to recognize and counter the constant threat of microbial infections. There is …
organisms to recognize and counter the constant threat of microbial infections. There is …
Use of CpG oligodeoxynucleotides as immune adjuvants
DM Klinman, D Currie, I Gursel… - Immunological …, 2004 - Wiley Online Library
Synthetic oligodeoxynucleotides (ODNs) containing unmethylated CpG motifs directly
stimulate human B cells and plasmacytoid dendritic cells (pDCs), thereby promoting the …
stimulate human B cells and plasmacytoid dendritic cells (pDCs), thereby promoting the …
[HTML][HTML] Immune adjuvant effect of molecularly-defined toll-like receptor ligands
DN Toussi, P Massari - Vaccines, 2014 - mdpi.com
Vaccine efficacy is optimized by addition of immune adjuvants. However, although adjuvants
have been used for over a century, to date, only few adjuvants are approved for human use …
have been used for over a century, to date, only few adjuvants are approved for human use …
Adjuvant activity of CpG oligodeoxynucleotides
DM Klinman - International reviews of immunology, 2006 - Taylor & Francis
Synthetic oligodeoxynucleotides (ODNs) containing unmethylated CpG motifs directly
stimulate human B cells and plasmacytoid dendritic cells (pDCs), thereby promoting the …
stimulate human B cells and plasmacytoid dendritic cells (pDCs), thereby promoting the …
Innate immunity stimulation via CpG oligodeoxynucleotides ameliorates Alzheimer's disease pathology in aged squirrel monkeys
AG Patel, PN Nehete, SR Krivoshik, X Pei, EL Cho… - Brain, 2021 - academic.oup.com
Alzheimer's disease is the most common cause of dementia and the only illness among the
top 10 causes of death for which there is no disease-modifying therapy. The failure rate of …
top 10 causes of death for which there is no disease-modifying therapy. The failure rate of …
Vaccine adjuvant: it makes the difference
KM Lima, SA dos Santos, JM Rodrigues Jr, CL Silva - Vaccine, 2004 - Elsevier
The use of protein or DNA in vaccination process rather than living or attenuated
microorganism, aims at the increase of the vaccines safety. However, in these cases, the use …
microorganism, aims at the increase of the vaccines safety. However, in these cases, the use …
CpG oligodeoxynucleotides stimulate protective innate immunity against pulmonary Klebsiella infection
JC Deng, TA Moore, MW Newstead, X Zeng… - The Journal of …, 2004 - journals.aai.org
Bacterial pneumonia is a leading cause of mortality in the United States. Innate immune
responses, including type-1 cytokine production, are critical to the effective clearance of …
responses, including type-1 cytokine production, are critical to the effective clearance of …
[HTML][HTML] Construction, stability, and activity of multivalent circular anticoagulant aptamers
DA Di Giusto, GC King - Journal of Biological Chemistry, 2004 - ASBMB
Here we describe the design and construction of multivalent circular DNA aptamers. Four
aptameric binding motifs directed at blood-borne targets are used as a model set from which …
aptameric binding motifs directed at blood-borne targets are used as a model set from which …